** Shares of Nova Eye Medical Ltd EYE.AX jump as much as
14% to A$0.285, their biggest intraday gain since July 3
** The medical technology firm says total U.S. sales of its
glaucoma surgical device in three months to July 31 were $2.2
mln, up 32%
** Says "solid" sales growth in the U.S. expected to
continue, with a targeted program of new customer account
acquisition to commence in late 2023
** Stock hits highest level since July 7; on track for a
second consecutive session of gains, if trend holds
** EYE stock down 10.7% YTD as of last close
(Reporting by Echha Jain in Bengaluru)
((Echha.jain@thomsonreuters.com))